Product correctly added to cart.

discount label
Netupitant N-Oxide
View 3D

Biosynth logo

Netupitant N-Oxide

CAS: 910808-11-6

Ref. 3D-KLB80811

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Friday 17 Jan 2025

Product Information

Name:
Netupitant N-Oxide
Description:

Netupitant is a neurokinin-1 receptor antagonist that inhibits the binding of substance P to its receptor. It is used as an antiemetic agent in patients receiving emetogenic chemotherapy, such as cyclophosphamide. Netupitant has been shown to be effective in reducing the incidence and severity of acute and delayed nausea and vomiting. The drug also binds to the serotonin 5-HT2A receptor, which may contribute to its efficacy in chemotherapy-induced nausea and vomiting. In addition, netupitant has been shown to inhibit the uptake of prodrugs by cells, which may increase their efficacy. This drug has not yet been approved for use on humans but is undergoing clinical trials for cancer treatment.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
594.59 g/mol
Formula:
C30H32F6N4O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-KLB80811 Netupitant N-Oxide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".